Trial · NCT00074711
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Lumbar Spine and Hip BMD, Measured as Grams Per Square Centimeter. | Calcium Phosphate Treatment Group | Baseline (Hip) | 0.76 | Standard Deviation 0.11 | g/cm2 |
| Lumbar Spine and Hip BMD, Measured as Grams Per Square Centimeter. | Calcium Carbonate Treatment Group | Baseline (Hip) | 0.78 | Standard Deviation 0.10 | g/cm2 |
| Lumbar Spine and Hip BMD, Measured as Grams Per Square Centimeter. | Calcium Phosphate Treatment Group | Baseline (Spine) | 0.88 | Standard Deviation 0.12 | g/cm2 |
| Lumbar Spine and Hip BMD, Measured as Grams Per Square Centimeter. | Calcium Carbonate Treatment Group | Baseline (Spine) | 0.86 | Standard Deviation 0.12 | g/cm2 |
| Bone Mineral Density (BMD) Under Treatment With an Anabolic Agent (Teriparatide). | Calcium Phosphate Treatment Group | Hip Bone Mineral Density | 0.01680 | Standard Error 0.00227 | g/cm2 |
| Bone Mineral Density (BMD) Under Treatment With an Anabolic Agent (Teriparatide). | Calcium Carbonate Treatment Group | Hip Bone Mineral Density | 0.01450 | Standard Error 0.00203 | g/cm2 |
| Bone Mineral Density (BMD) Under Treatment With an Anabolic Agent (Teriparatide). | Calcium Phosphate Treatment Group | Spine Bone Mineral Density | 0.0609 | Standard Error 0.00356 | g/cm2 |
| Bone Mineral Density (BMD) Under Treatment With an Anabolic Agent (Teriparatide). | Calcium Carbonate Treatment Group | Spine Bone Mineral Density | 0.0607 | Standard Error 0.00336 | g/cm2 |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Phosphate Treatment Group | S Phos | 0.139 | Standard Error 0.045 | mg/dl |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Carbonate Treatment Group | S Phos | 0.245 | Standard Error 0.042 | mg/dl |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Phosphate Treatment Group | S Crt | -0.001 | Standard Error 0.012 | mg/dl |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Carbonate Treatment Group | S Crt | 0.051 | Standard Error 0.012 | mg/dl |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Phosphate Treatment Group | S Ca | -0.048 | Standard Error 0.041 | mg/dl |
| Change From Baseline in Serum Phosphorus, Serum Creatinine, Serum Calcium at 12 Months | Calcium Carbonate Treatment Group | S Ca | 0.001 | Standard Error 0.047 | mg/dl |
| Change From Baseline in Urinary Calcium to Creatinine Ratio, Urinary Phosphorus to Creatinine Ratio at 12 Months | Calcium Phosphate Treatment Group | Ca to CRT | 0.021 | Standard Error 0.010 | g/g |
| Change From Baseline in Urinary Calcium to Creatinine Ratio, Urinary Phosphorus to Creatinine Ratio at 12 Months | Calcium Carbonate Treatment Group | Ca to CRT | 0.011 | Standard Error 0.010 | g/g |
| Change From Baseline in Urinary Calcium to Creatinine Ratio, Urinary Phosphorus to Creatinine Ratio at 12 Months | Calcium Phosphate Treatment Group | Ph to CRT | 0.073 | Standard Error 0.025 | g/g |
| Change From Baseline in Urinary Calcium to Creatinine Ratio, Urinary Phosphorus to Creatinine Ratio at 12 Months | Calcium Carbonate Treatment Group | Ph to CRT | -0.053 | Standard Error 0.028 | g/g |
| Change From Baseline in Urinary N-telopeptide at 12 Months | Calcium Phosphate Treatment Group | 16.0 | Standard Error 3.42 | nmol bce/mmol | |
| Change From Baseline in Urinary N-telopeptide at 12 Months | Calcium Carbonate Treatment Group | 17.1 | Standard Error 2.79 | nmol bce/mmol |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00074711/results